Cephalexin Capsule
Product Images NDC 71205-591

2 FDA label images from Proficient Rx Lp · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Cephalexin (NDC 71205-591). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Cephalexin Capsule Powder For Suspension A062702 A 1)

Structure (Cephalexin Capsule Powder For Suspension A062702 A 1)
Chemical structure of cephalexin showing its molecular components including a beta-lactam ring, a thiazolidine ring, and associated functional groups, along with a water molecule (H2O) indicating a hydrate form.*
FDA Label Image

71205-591-06 (Cephalexin Capsule Powder For Suspension A062702 A 3)

71205-591-06 (Cephalexin Capsule Powder For Suspension A062702 A 3)
Cephalexin 500 mg capsules label from Proficient Rx LP, indicating prescription use. The label includes active ingredient information as cephalexin monohydrate USP equivalent to 500 mg cephalexin. It notes capsule appearance (Swedish orange body and cap with imprints). Manufactured by Teva Pharmaceuticals USA and packaged by EPM Packaging. Storage temperature and medication safety warning are included.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.